What is the official website of Pharma forum ?

The official website of Pharma forum is https://www.pharmaforum.be/fr/.

What is Pharma forum's cybersecurity risk score?

Pharma forum has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Pharma forum experienced?

According to Rankiteo, Pharma forum currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Pharma forum been affected by any supply chain cyber incidents ?

According to Rankiteo, Pharma forum has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Pharma forum have SOC 2 Type 1 certification ?

According to Rankiteo, Pharma forum is not certified under SOC 2 Type 1.

Does Pharma forum have SOC 2 Type 2 certification ?

According to Rankiteo, Pharma forum does not hold a SOC 2 Type 2 certification.

Does Pharma forum comply with GDPR ?

According to Rankiteo, Pharma forum is not listed as GDPR compliant.

Does Pharma forum have PCI DSS certification ?

According to Rankiteo, Pharma forum does not currently maintain PCI DSS compliance.

Does Pharma forum comply with HIPAA ?

According to Rankiteo, Pharma forum is not compliant with HIPAA regulations.

Does Pharma forum have ISO 27001 certification ?

According to Rankiteo,Pharma forum is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Pharma forum operate in ?

Pharma forum operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Pharma forum have ?

Pharma forum employs approximately None employees people worldwide.

Does Pharma forum own any subsidiaries ?

Pharma forum presently has no subsidiaries across any sectors.

How many LinkedIn followers does Pharma forum have ?

Pharma forum's official LinkedIn profile has approximately 385 followers.

What is the NAICS classification code for Pharma forum ?

Pharma forum is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Pharma forum have a Crunchbase profile ?

No, Pharma forum does not have a profile on Crunchbase.

Does Pharma forum have a LinkedIn profile ?

Yes, Pharma forum maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/pharma-forum.

How many cybersecurity incidents has Pharma forum experienced ?

As of August 23, 2026, Rankiteo reports that Pharma forum has not experienced any cybersecurity incidents.

How many peer or competitor companies does Pharma forum have ?

Pharma forum has an estimated 5,730 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Pharma forum

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Pharma forum Vendor Cyber Rating & Cyber Score

pharmaforum.be

Add Your Compliance Badge

Pharma forum est le rendez-vous incontournable pour les gérants d'officines, pharmaciens et assistants pharmaciens. Pharma forum, c'est également l’occasion idéale de multiplier vos contacts et de vous positionner comme l’une des sociétés incontournables du secteur, grâce à deux journées complètes de formations, de conférences et d'ateliers accrédités, de découvertes et de networking. Venez rencontrer vos nouveaux prospects et toucher un visitorat décisionnaire les 24 et 25 septembre 2022 à Pharma forum !

Pharma forum A.I CyberSecurity Scoring

Scoring History

Pharma forum

Pharma forum CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Pharma forum Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Pharma forum

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Pharma forum in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Pharma forum in 2026.

Incident Types Pharma forum vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Pharma forum in 2026.

Incident History - Pharma forum (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Pharma forum Subsidiaries

Pharma forum

Pharmaceutical Manufacturing

Website: https://www.pharmaforum.be/fr/

Company Size: None employees

152

EasyfairsEvents Services

Easyfairs NordicEvents Services

ByggmässanEvenemangstjänster

Advanced Engineering & ElektronikmässanEvents Services

SettProgram för utbildningsadministration

Personal & ChefStaffing and Recruiting

FastighetsMässanEvenemangstjänster

Empack SwedenPackaging & Containers

Light & DesignTillverkning av elektrisk belysningsutrustning

Fastfood & Café & Restaurant Expo FinlandEvents Services

VVS-mässanEvenemangstjänster

FFCR SverigeEvents Services

Industrimässorna ÖresundEvenemangstjänster

TechdaysStrategic Management Services

Ekonomi & FöretagIndustry Associations

ElmässanEvents Services

Advanced Engineering UKEvents Services

Easyfairs NordicEvents Services

Easyfairs NetherlandsEvents Services

HortiContactEvents Services

Rotterdam Processing WeekEvents Services

CamperbeursEvents Services

Dental ExpoEvents Services

Maritime IndustryEvents Services

EmpackNLEvenementenservices

Aqua NederlandEvenementenservices

Visualize ExpoEvents Services

Infra RelatiedagenEvenementenservices

Recreatie VakbeursRecreatievoorzieningen

Futurebuild HollandConstruction

InstallTech & BouwEvents Services

Rundvee & Mechanisatie VakdagenEvenementenservices

TrendzEvenementenservices

Future LightingEvenementenservices

Packaging Innovations NLEvents Services

Recycling & Circulair NextEvents Services

Afbouw VakdagenEvenementenservices

Installatie VakdagenEvents Services

Recreatie Next LevelEvenementenservices

Maintenance GorinchemEvenementenservices

Vakbeurs Bakkersvak & IJs-VakEvenementenservices

Dutch Pork ExpoEvents Services

Huis & Woon BeursEvenementenservices

Worksafe GorinchemEvents Services

The Hair X-perienceEvenementenservices

Horeca VakbeursEvenementenservices

Tuin & Park ExpoEvenementenservices

Dutch Pork & Poultry ExpoEvents Services

Bouw RelatiedagenEvenementenservices

Schilders VakdagenEvents Services

M+R RotterdamEvents Services

Vakbeurs Logistics & AutomationTransportation, Logistics, Supply Chain and Storage

Welding Week NederlandEvents Services

InfraNXTEvents Services

Vakbeurs Auto ProfProductie motorvoertuigen

Elektro VakbeursEvenementenservices

InCoDaEvenementenservices

Automation NederlandEvents Services

Pumps & Valves RotterdamEvenementenservices

De Dag van het AmbachtEvents Services

Beauty DaysEvenementenservices

VelovakEvenementenservices

Solids RotterdamEvents Services

De Groene Sector VakbeursEvenementenservices

METAVAKEvenementenservices

Packaging Innovations & EmpackEvents Services

Inspire Health & CareHospitals and Health Care

Connect In PharmaPharmaceutical Manufacturing

Easyfairs IberiaEvents Services

Worksafe BarcelonaEvents Services

Logistic & Industrial Build SpainConstruction

bis, bouw- en interieursalonEvents Services

Easyfairs SwitzerlandEvents Services

EMPACK SchweizVeranstaltungsdienste

maintenance SchweizVeranstaltungsdienste

PUMPS-VALVES ZurichVeranstaltungsdienste

LOGISTICS & AUTOMATION SchweizEvents Services

AQUA SuisseEvents Services

SOLIDS ZurichVeranstaltungsdienste

Green - event voor de groenprofessionalEvents Services

Easyfairs Events TechnologyTechnology, Information and Internet

StocExpo & Tank StorageEvents Services

Packaging Innovations NederlandEvents Services

Dentex Algeriaخدمات المناسبات

Easyfairs GermanyEvents Services

maintenanceEvents Services

FMB – Fachmesse für MaschinenbauEvents Services

SOLIDS, RECYCLING-TECHNIK und PUMPS & VALVES DortmundEvents Services

all about automationEvents Services

SOLIDS ParmaEvents Services

LOGISTICS & AUTOMATIONEvents Services

KPA - Kunststoff Produkte AktuellEvents Services

EMPACKEvents Services

Transport & Logistics NRW 2018Events Services

SEAQUIPEvents Services

Easyfairs ItalyEvents Services

Easyfairs UKEvents Services

PENTAWARDSAdvertising Services

MAGHREB PHARMA Expo & Conférenceخدمات المناسبات

AestheticsEvents Services

Packaging Première & PCD MilanEvents Services

StocExpoOil and Gas

Tank Storage MagazineOil and Gas

FuturebuildConstruction

Paris Packaging WeekEvents Services

Advanced Manufacturing ESServicios de eventos

Logistics & Automation SpainTransportation, Logistics, Supply Chain and Storage

Packaging Première & PCD MilanServizi per eventi

StocExpoOil and Gas

AntwerpXLMaritime Transportation

Lab InnovationsEvents Services

Empack SpainPackaging and Containers Manufacturing

London Packaging WeekEvents Services

Empack and Logistics & Automation PortoTransporte, armazenagem e correio

CCR LondonEvents Services

MAGHREB PHARMA HorizonPharmaceutical Manufacturing

Horeca ExpoHospitality

Bois & HabitatConstruction

Sett Namur ExpoEducation Management

Namur ExpoEvents Services

Loading…

Pharma forum Similar Companies

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Loading…

NEWS

Pharma forum CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-78122

SUMMARY

docker-socket-proxy fails to properly gate read endpoints in the /containers Docker API namespace when the CONTAINERS environment variable is set. Attackers can use GET requests to /containers/{id}/archive, /containers/{id}/export, /containers/{id}/logs, and /containers/{id}/top to read arbitrary files and download entire container filesystems as tar archives.

Published

Date2026-08-22

Updated

Date2026-08-22

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

cvss4

Base Score: 8.3

Complexity: LOW

CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

2.8

REFERENCES

CVE-2026-78049

SUMMARY

A vulnerability has been found in Systerel S2OPC up to 1.7.3. Impacted is the function SOPC_NodeMgtHelperInternal_AddVariableNodeAttributes of the file src/ClientServer/address_space/internal/sopc_node_mgt_helper_internal.c of the component AddNodes Service. The manipulation of the argument UserAccessLevel leads to out-of-bounds read. It is possible to initiate the attack remotely. A high degree of complexity is needed for the attack. The exploitability is considered difficult. The exploit has been disclosed to the public and may be used. The identifier of the patch is aafbd37d381b618312ebdf5ddf57027f62c14fdd. It is suggested to install a patch to address this issue.

Published

Date2026-08-22

Updated

Date2026-08-22

RISK INFORMATION (Score: 3.7)

cvss2

Base Score: 2.6

Complexity: HIGH

AV:N/AC:H/Au:N/C:N/I:N/A:P

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 2.9

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.2

REFERENCES

CVE-2026-12999

SUMMARY

The Infineon Airoc Wi-Fi driver's transmit callback airoc_mgmt_send() in drivers/wifi/infineon/airoc_wifi.c allocates a net_buf from the fixed airoc_pool for every outbound packet. When whd_network_send_ethernet_data() returns a synchronous failure, the underlying WHD library does not take ownership of the buffer, but the pre-fix driver returned -EIO without releasing it. Each failed transmit therefore permanently leaks one buffer from the pool. airoc_pool is small and fixed (AIROC_WIFI_TX_PACKET_POOL_COUNT + AIROC_WIFI_RX_PACKET_POOL_COUNT, default 20 buffers) and is shared by WHD's whd_host_buffer_get callback for both transmit and receive. Once enough send failures have leaked the pool dry, airoc_wifi_host_buffer_get() returns WHD_BUFFER_ALLOC_FAIL for all subsequent allocations, so both transmit and the WHD-driven receive path fail and Wi-Fi connectivity is lost until the device is rebooted. The leak occurs only on the transmit error path. A Wi-Fi-adjacent attacker can influence the conditions that cause synchronous send failures (for example by deauthenticating/disassociating the station while the local stack continues to attempt transmits), and ordinary transient failures over the device's lifetime accumulate toward the same state. Reliable on-demand triggering is of high complexity and the impact is availability-only, but the resulting denial of service is permanent and non-recoverable without a reboot. The fix releases the buffer with airoc_wifi_buffer_release() on the failure branch, returning it to the pool. The commit also removes a redundant k_sem_give() in airoc_mgmt_disconnect(); because data->sema_common is a binary semaphore (limit 1) the duplicate give merely saturated at 1 and had no security impact.

Published

Date2026-08-22

Updated

Date2026-08-22

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: HIGH

CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.6

REFERENCES

CVE-2026-74733

SUMMARY

In the Linux kernel, the following vulnerability has been resolved: gpio: pca953x: fix pca953x_irq_bus_sync_unlock regmap lock Locking is disabled in the regmap config as this driver uses its own lock. This means that all calls to regmap functions (read or write) must hold the i2c_lock. The function pca953x_irq_bus_sync_unlock() did not do this, and it was therefore possible that multiple threads could cause an incorrect register to be read/written. A previous patch partly fixed this, but only protected the write to the interrupt mask register, and not the read from the direction register.

Published

Date2026-08-22

Updated

Date2026-08-22

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-74732

SUMMARY

In the Linux kernel, the following vulnerability has been resolved: drm/amd/display: Check for tg ops in dce110_set_avmute Some older DCE timing generators do not implement is_tg_enabled in their ops table. Calling it unconditionally when waiting for AV mute frames causes a NULL pointer dereference on Southern Islands dGPUs when turning the display off over HDMI. Check that tg and the required ops exist before waiting for frames. (cherry picked from commit 2686a0c0aaa07bec2e24131835cf27b5fd4935a5)

Published

Date2026-08-22

Updated

Date2026-08-22

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…